These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 23153407

  • 1. Measurement and clinical effect of grey matter pathology in multiple sclerosis.
    Geurts JJ, Calabrese M, Fisher E, Rudick RA.
    Lancet Neurol; 2012 Dec; 11(12):1082-92. PubMed ID: 23153407
    [Abstract] [Full Text] [Related]

  • 2. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P.
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [Abstract] [Full Text] [Related]

  • 3. Grey matter pathology in multiple sclerosis.
    Bö L, Geurts JJ, Mörk SJ, van der Valk P.
    Acta Neurol Scand Suppl; 2006 Oct; 183():48-50. PubMed ID: 16637929
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exploring the origins of grey matter damage in multiple sclerosis.
    Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R.
    Nat Rev Neurosci; 2015 Mar; 16(3):147-58. PubMed ID: 25697158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L.
    Acta Neurol Scand Suppl; 2009 Mar; (189):51-7. PubMed ID: 19566500
    [Abstract] [Full Text] [Related]

  • 11. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H.
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [Abstract] [Full Text] [Related]

  • 12. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D, Miller D.
    J Neurol Sci; 2009 Jul 15; 282(1-2):5-11. PubMed ID: 19201002
    [Abstract] [Full Text] [Related]

  • 13. MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
    Jacobsen CO, Farbu E.
    Acta Neurol Scand Suppl; 2014 Jul 15; (198):32-6. PubMed ID: 24588504
    [Abstract] [Full Text] [Related]

  • 14. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM.
    J Neurol; 2002 Sep 15; 249(9):1279-86. PubMed ID: 12242554
    [Abstract] [Full Text] [Related]

  • 15. Gray matter pathology in (chronic) MS: modern views on an early observation.
    Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):12-20. PubMed ID: 19249061
    [Abstract] [Full Text] [Related]

  • 16. Grey matter atrophy in patients suffering from multiple sclerosis.
    Kincses ZT, Tóth E, Bankó N, Veréb D, Szabó N, Csete G, Faragó P, Király A, Bencsik K, Vécsei L.
    Ideggyogy Sz; 2014 Sep 30; 67(9-10):293-300. PubMed ID: 25518257
    [Abstract] [Full Text] [Related]

  • 17. Cortical lesions and brain atrophy in MS.
    Kutzelnigg A, Lassmann H.
    J Neurol Sci; 2005 Jun 15; 233(1-2):55-9. PubMed ID: 15893328
    [Abstract] [Full Text] [Related]

  • 18. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 15; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 19. Grey matter damage in multiple sclerosis: a pathology perspective.
    Klaver R, De Vries HE, Schenk GJ, Geurts JJ.
    Prion; 2013 Sep 15; 7(1):66-75. PubMed ID: 23324595
    [Abstract] [Full Text] [Related]

  • 20. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
    Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R.
    Brain; 2013 Dec 15; 136(Pt 12):3596-608. PubMed ID: 24176976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.